Santa Ana Bio stock

Santa Ana Bio Stock

HealthTech
Founded: 2020Funding to Date: $168Mhttps://www.santaanabio.com

Santa Ana Bio, a biotechnology company, focuses on advancing precision immunology to treat autoimmune diseases. By utilizing single-cell genomics and sophisticated analytics, the company crafts personalized biologics tailored for autoimmune conditions. This approach allows patients to access targeted and effective treatments, resulting in expected outcomes and an enhanced quality of life.

Investors Include:

RTW Investments, Access Biotechnology, GV, Versant Ventures, Andreessen Horowitz, TPG.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Unlock My Liquidity